You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Public Health, 24 June 2025

Sec. Public Health Education and Promotion

Volume 13 - 2025 | https://doi.org/10.3389/fpubh.2025.1617766

Corrigendum: Assessing knowledge, attitudes, and practices toward sexually transmitted infections among Baghdad undergraduate students for research-guided sexual health education

  • 1. College of Medicine, University of Baghdad, Baghdad, Iraq

  • 2. Department of Community and Family Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq

Article metrics

View details

838

Views

173

Downloads

In the published article, there was an error. The proportion of participants who believed that HIV could be completely cured was reported as 32.9% in the text instead of the correct figure of 23.9%, which could be derived from Table 2. A correction has been made to [Results], [Knowledge of sexually transmitted infections]. This sentence previously stated:

“These include: the availability of HIV vaccination (standing at 42% incorrect response rate), the non-curability of HIV infections (32.9%), …”

The corrected sentence appears below:

“These include: the availability of HIV vaccination (standing at 42% incorrect response rate), the non-curability of HIV infections (23.9%), …”

In the published article, there was an error. The proportion of participants who believed that HIV is a non-curable infection was reported as 67.1% in the text instead of 76.1%, which could be derived from Table 2.

A correction has been made to the [Discussion], Paragraph 3. This sentence previously stated:

“As for other HIV items, only 58% of respondents correctly identified the unavailability of a vaccine, and 67.1% correctly identified HIV as a non-curable infection.”

The corrected sentence appears below:

“As for other HIV items, only 58% of respondents correctly identified the unavailability of a vaccine, and 76.1% correctly identified HIV as a non-curable infection.”

In the published article, there was an error in Table 2 as published. The “c” superscript denoting “No” as the correct answer was not placed for two items: “Showering before and after sex” and “contraceptive pill”. The corrected Table 2 and its caption appear below.

Table 2

Category Gender Do you know someone who has been diagnosed with an STI? Previous sexual experience
Male 332 (%)a Female
491 (%)a
p-valueb Yes
195 (%)a
No 628 (%)a p-valueb Yes 226 (%)a No
597 (%)a
p-valueb
Diseases
HIV 326 (98.2) 482 (98.2) 0.978 189 (96.9) 619 (98.6) 0.134 220 (97.3) 588 (98.5) 0.272
Syphilis 124 (37.3) 156 (31.8) 0.098 89 (42.6) 197 (31.4) 0.004 91 (40.3) 189 (31.7) 0.020
Gonorrhea 224 (67.5) 254 (51.7) 7 * 10 −6 138 (70.8) 340 (54.1) 5 * 10 −5 160 (70.8) 318 (53.3) 5 * 10 −6
Genital warts 83 (25.0) 144 (29.3) 0.173 67 (34.3) 160 (25.5) 0.015 80 (35.4) 147 (24.6) 0.002
Genital herpes 154 (46.4) 243 (49.5) 0.382 106 (54.4) 291 (46.3) 0.050 110 (48.7) 287 (48.1) 0.878
Chlamydia 84 (25.3) 117 (23.8) 0.630 59 (30.3) 142 (22.6) 0.030 65 (28.8) 136 (22.8) 0.075
Trichomoniasis 65 (19.6) 106 (21.6) 0.486 51 (26.2) 120 (19.1) 0.034 52 (23.0) 119 (19.9) 0.332
Molluscum 97 (29.2) 136 (27.7) 0.635 77 (39.5) 156 (24.8) 1 * 10 −4 73 (32.3) 160 (26.8) 0.118
Scabies and pediculosis 144 (43.3) 229 (46.6) 0.356 108 (55.4) 265 (42.2) 0.001 101 (44.7) 272 (45.6) 0.823
Hepatitis B and C 160 (48.2) 243 (49.5) 0.715 108 (55.4) 295 (47.0) 0.040 108 (47.8) 295 (49.4) 0.677
Symptoms
Groin swelling 168 (50.6) 258 (52.5) 0.584 119 (61.0) 307 (48.9) 0.003 127 (56.2) 299 (50.1) 0.117
Genital ulcers 247 (74.4) 414 (84.3) 6 * 10 −4 170 (87.2) 491 (78.2) 0.006 183 (81.0) 478 (80.1) 0.770
Genital itching 235 (70.8) 366 (74.5) 0.233 157 (80.5) 444 (70.7) 0.007 184 (81.4) 417 (69.8) 0.001
Genital rash 241 (72.6) 369 (75.2) 0.410 156 (80.0) 454 (72.3) 0.032 175 (77.4) 435 (72.9) 0.182
Groin pain 172 (51.8) 290 (59.1) 0.040 128 (65.6) 334 (53.2) 0.012 128 (56.6) 334 (55.9) 0.859
Painful urination 203 (61.1) 282 (57.4) 0.288 121 (62.1) 364 (58.0) 0.311 140 (61.9) 345 (57.8) 0.279
Menstrual issues 179 (53.9) 257 (52.3) 0.657 112 (57.4) 324 (51.6) 0.153 127 (56.2) 309 (51.8) 0.255
Vaginal discharge 214 (64.5) 335 (68.2) 0.260 142 (72.8) 407 (64.8) 0.038 159 (70.4) 390 (65.3) 0.172
Urethral discharge 195 (58.7) 303 (61.7) 0.392 133 (68.2) 365 (58.1) 0.002 140 (61.9) 358 (60.0) 0.604
Body rash 135 (40.7) 202 (41.1) 0.891 87 (44.6) 250 (39.8) 0.233 93 (41.2) 244 (40.9) 0.942
Fever 140 (42.2) 217 (44.2) 0.565 104 (53.3) 253 (40.3) 0.001 98 (43.4) 259 (43.4) 0.996
Frequent diarrhea 96 (28.9) 127 (25.9) 0.334 59 (30.3) 164 (26.1) 0.256 57 (25.2) 166 (27.8) 0.457
Frequent coughing 78 (23.5) 92 (18.7) 0.098 49 (25.1) 121 (19.3) 0.077 48 (21.2) 122 (20.4) 0.799
Frequent sore throat 66 (19.9) 90 (18.3) 0.564 42 (21.5) 114 (18.2) 0.296 44 (19.6) 112 (18.8) 0.795
Weight loss 122 (36.7) 187 (38.1) 0.697 80 (41.0) 229 (36.5) 0.251 78 (34.5) 231 (38.7) 0.269
No symptoms 275 (82.8) 397 (80.9) 0.472 167 (85.6) 505 (80.4) 0.099 187 (82.7) 485 (81.2) 0.619
Transmission
Sexual intercourse 325 (97.9) 485 (98.8) 0.317 191 (97.9) 619 (98.6) 0.545 222 (98.2) 588 (98.5) 0.788
Skin contact 125 (37.7) 198 (40.3) 0.441 96 (49.2) 227 (36.1) 0.001 98 (43.4) 225 (37.7) 0.137
Sharing objects 192 (57.8) 369 (75.2) 1 * 10 −7 144 (73.8) 417 (66.4) 0.051 153 (67.7) 408 (68.3) 0.860
Sharing foodc 166 (50.0) 196 (39.9) 0.004 110 (56.4) 252 (40.1) 8 * 10 −5 103 (45.6) 259 (43.4) 0.572
Swimming poolsc 230 (69.3) 415 (84.5) 1 * 10 −7 163 (83.6) 482 (76.8) 0.043 180 (79.6) 465 (77.9) 0.585
Blood and injections 304 (91.6) 430 (87.6) 0.071 181 (92.8) 553 (88.1) 0.061 203 (89.8) 531 (88.9) 0.717
Hairdressing 243 (73.2) 378 (77.0) 0.215 164 (84.1) 457 (72.8) 0.001 177 (78.3) 444 (74.4) 0.240
Pregnancy and childbirth 184 (55.4) 240 (48.9) 0.065 118 (60.5) 306 (48.7) 0.004 131 (58.0) 293 (49.1) 0.023
Breastfeeding 174 (52.4) 180 (36.7) 7 * 10 −6 101 (51.8) 253 (40.3) 0.005 110 (48.7) 244 (40.9) 0.044
Mosquito bitec 203 (61.1) 281 (57.2) 0.263 130 (66.7) 354 (56.4) 0.011 143 (63.3) 341 (57.1) 0.109
Risk factors
Multiple partners 324 (97.6) 476 (96.9) 0.582 190 (97.4) 610 (97.1) 0.823 220 (97.3) 580 (97.2) 0.881
Unprotected sex 300 (90.4) 386 (78.6) 9 * 10 −6 169 (86.7) 517 (82.3) 0.155 190 (84.1) 496 (83.1) 0.734
Substance use 222 (66.9) 357 (72.7) 0.072 145 (74.4) 434 (69.1) 0.161 148 (65.5) 431 (72.2) 0.060
Prostitution 311 (93.7) 452 (92.1) 0.381 184 (94.4) 579 (92.2) 0.310 213 (94.2) 550 (92.1) 0.296
STI co-infection 309 (93.1) 452 (92.1) 0.588 187 (95.9) 574 (91.4) 0.038 211 (93.4) 550 (92.1) 0.549
Multiple marriages 180 (54.2) 396 (80.7) 4 * 10 −16 148 (75.9) 428 (68.2) 0.039 155 (68.6) 136 (22.8) 0.589
Prevention
Abstinenced 155 (46.7) 230 (46.8) 0.965 95 (48.7) 290 (46.2) 0.535 93 (41.2) 292 (48.9) 0.046
Condoms 287 (86.4) 371 (75.6) 1 * 10 −4 165 (84.6) 493 (78.5) 0.063 192 (85.0) 466 (78.1) 0.027
Single partner 268 (80.7) 455 (92.7) 2 * 10 −7 168 (86.2) 555 (88.4) 0.407 190 (84.1) 533 (89.3) 0.041
Routine check-up 307 (92.5) 477 (97.1) 0.002 187 (95.9) 597 (95.1) 0.632 212 (93.8) 572 (95.8) 0.226
Vaccines (warts) 278 (83.7) 437 (89.0) 0.028 169 (86.7) 546 (86.9) 0.921 197 (87.2) 518 (86.8) 0.879
Vaccines (HIV)c 120 (36.1) 226 (46.0) 0.005 95 (48.7) 251 (40.0) 0.031 98 (43.4) 248 (41.5) 0.637
Showering before and after sexc 301 (90.7) 457 (93.1) 0.208 181 (92.8) 577 (91.9) 0.670 208 (92.0) 550 (92.1) 0.965
Contraceptive pillc 130 (39.2) 193 (39.3) 0.965 90 (46.2) 233 (37.1) 0.024 88 (38.9) 235 (39.4) 0.911
Circumcision 238 (71.7) 356 (72.5) 0.797 140 (71.8) 454 (72.3) 0.892 164 (72.6) 430 (72.0) 0.877
Outcome
Resolution (HIV)c 83 (25.0) 114 (23.2) 0.557 58 (29.7) 139 (22.1) 0.030 70 (31.0) 127 (21.3) 0.004
Resolution (others)c 214 (64.5) 285 (58.0) 0.065 127 (65.1) 372 (59.2) 0.141 139 (61.5) 360 (60.3) 0.753
Infertility 178 (53.6) 262 (53.4) 0.943 107 (54.9) 333 (53.0) 0.652 125 (55.3) 315 (52.8) 0.513
Abortion 198 (59.6) 326 (66.4) 0.048 133 (68.2) 391 (62.3) 0.132 143 (63.3) 381 (63.8) 0.885
Premature birth 149 (44.9) 254 (51.7) 0.054 99 (50.8) 304 (48.4) 0.564 126 (55.8) 277 (46.4) 0.017
Birth defects 201 (60.5) 303 (61.7) 0.736 123 (63.1) 381 (60.7) 0.547 143 (63.3) 361 (60.5) 0.461
Kidney problems 260 (78.3) 361 (73.5) 0.117 163 (83.6) 458 (72.9) 0.003 177 (78.3) 444 (74.4) 0.240
Cancer 193 (58.1) 313 (63.7) 0.104 127 (65.1) 379 (60.4) 0.231 140 (61.9) 366 (61.3) 0.866
Death 219 (66.0) 318 (64.8) 0.723 137 (70.3) 400 (63.7) 0.093 143 (63.3) 394 (66.0) 0.464
Information source
School 170 (51.2) 249 (50.7) 0.890 95 (48.7) 324 (51.6) 0.483 111 (49.1) 308 (51.6) 0.526
Healthcare providers 148 (44.6) 194 (39.5) 0.148 99 (50.8) 243 (38.7) 0.003 104 (46.0) 238 (39.9) 0.110
Parents 93 (28.0) 159 (32.4) 0.182 75 (38.5) 177 (28.2) 0.007 69 (30.5) 183 (30.7) 0.973
Friends 216 (65.1) 212 (43.2) 7 * 10 −10 121 (62.1) 307 (48.9) 0.001 146 (64.6) 282 (47.2) 8 * 10 −6
Books 207 (62.3) 279 (56.8) 0.114 124 (63.6) 362 (57.6) 0.140 154 (68.1) 332 (55.6) 0.001
TV 188 (56.6) 270 (55.0) 0.643 111 (56.9) 347 (55.3) 0.682 134 (59.3) 324 (54.3) 0.196
The Internet 313 (94.6) 451 (91.9) 0.137 183 (93.8) 581 (92.7) 0.573 211 (93.8) 553 (92.6) 0.567

Knowledge about sexually transmitted infections among non-medical undergraduates in Baghdad, Iraq.

aCounts and column percent are described as individuals who have answered “Yes” during data collection.

bChi-square for association with a cutoff point of 0.05 for p-value and significant results indicated with a bold text.

cFor these questions, “No” was the correct answer.

dDuring data collection, abstinence was described as restraining from sexual experience before marriage.

In the published article, there was missing information. Effect size indices were not reported for Tables B1, C2, D1. This information is now included in Supplementary Table 1. For cases where equality of variance could be assumed, based on Levene's test, the Cohen's D index is reported. Alternatively, the mean difference was scaled by the square root of the average variance (instead of the pooled variance) as a more accurate indicator of the effect size (1). For both indices, a value of ≥0.2 signifies a small effect, ≥0.5 signifies a moderate effect, and ≥0.8 for a large effect.

Supplementary Table 1

Scale Categorical variable Groups Mean (SD) Mean difference Levene's Test T-test Effect size
Knowledge score Gender Male 34.82 (±6.8) 0.450 F = 1.359 t = −0.952a −0.068c
Female 35.27 (±6.5) p = 0.244 p = 0.341
Do you know someone with an STD? Yes 37.17 (±6.7) 2.730 F = 0.121 t = 5.076a 0.416c
No 34.44 (±6.4) p = 0.728 p = 4.8*10−7
Previous sexual experience Yes 35.77 (±7.0) 0.935 F = 2.317 t = 1.802a 0.141c
No 34.83 (±6.4) p = 0.128 p = 0.072
Sex education should be taught in school Yes 35.42 (±6.6) 2.307 F = 0.249 t = 3.519a 0.349c
No 33.11 (±6.6) p = 0.618 p = 4.5*10−4
Age (Years) Previous sexual experience Yes 23.74 (±4.7) 2.050 F = 34.015 t = 6.033b 0.525d
No 21.69 (±2.9) p = 7.9*10−9 p = 4.8*10−9

Effect size indices for independent samples T-test (N = 823).

aStudent's independent samples T-test was used to test for association with 0.05 as a cut-off point for statistical significance.

bWelch's independent samples T-test was used to test for association with 0.05 as a cut-off point for statistical significance.

cCohen's D was used to assess effect size with ≥0.2 for small, ≥0.5 for moderate, and ≥0.8 for large effect sizes.

dThe mean difference scaled by the square root of the average variance was used to assess effect size with ≥0.2 for small, ≥0.5 for moderate, and ≥0.8 for large effect sizes.

In the published article, in Tables 24, a large number of hypothesis testing was performed simultaneously to test the association between each item and the three independent variables (gender, knowing someone who has been diagnosed with a sexually transmitted infection, and previous sexual experience). To further strengthen statistical reporting, the Benjamin-Hochberg procedure could be utilized to adjust p-values for multiple testing and reduce the false discovery rate to 5% within each family of hypothesis tests (within each independent variable) (2). This information is now provided in Supplementary Tables 24, which also include the odds ratio as an index of effect size to improve the interpretability of the statistically significant associations.

Supplementary Table 2

Category Gender Do you know someone who has been diagnosed with an STI? Previous sexual experience
Odds ratio (95% CI) Adjusted p-valuea, b Odds ratio (95% CI) Adjusted p-valuea, b Odds ratio (95% CI) Adjusted p-valuea, b
Diseases
HIV 1.01 (0.36–2.88) 0.978 0.46 (0.16–1.30) 0.268 0.56 (0.20–1.60) 0.698
Syphilis 1.28 (0.96–1.72) 0.267 1.62 (1.17–2.26) 0.026 1.46 (1.06–2.00) 0.180e
Gonorrhea 1.94 (1.45–2.59) 7.9 * 10 −5 2.05 (1.45–2.90) 0.004 2.13 (1.53–2.95) 3.6 * 10 −4
Genital warts 0.80 (0.59–1.10) 0.380 1.53 (1.08–2.16) 0.064e 1.68 (1.21–2.33) 0.030
Genital herpes 0.88 (0.67–1.17) 0.608 1.38 (1.00–1.90) 0.131 1.02 (0.75–1.39) 0.971
Chlamydia 1.08 (0.78–1.50) 0.769 1.48 (1.04–2.12) 0.107e 1.37 (0.97–1.93) 0.355
Trichomoniasis 0.88 (0.63–1.25) 0.673 1.50 (1.03–2.18) 0.109e 1.20 (0.83–1.74) 0.747
Molluscum 1.08 (0.79–1.47) 0.769 1.97 (1.41–2.77) 0.011 1.30 (0.94–1.82) 0.462
Scabies and pediculosis 0.88 (0.66–1.16) 0.593 1.70 (1.23–2.35) 0.011 0.97 (0.71–1.31) 0.971
Hepatitis B and C 0.95 (0.72–1.25) 0.798 1.40 (1.01–1.94) 0.113e 0.94 (0.69–1.27) 0.971
Symptoms
Groin swelling 0.93 (0.70–1.22) 0.745 1.64 (1.18–2.27) 0.023 1.28 (0.94–1.74) 0.462
Genital ulcers 0.54 (0.38–0.76) 0.004 1.90 (1.20–3.01) 0.034 1.06 (0.72–1.56) 0.971
Genital itching 0.83 (0.61–1.13) 0.450 1.71 (1.15–2.54) 0.035 1.89 (1.30–2.76) 0.018
Genital rash 0.88 (0.64–1.20) 0.620 1.53 (1.04–2.27) 0.107e 1.28 (0.89–1.83) 0.585
Groin pain 0.75 (0.56–0.99) 0.157e 1.68 (1.20–2.35) 0.054e 1.03 (0.76–1.40) 0.971
Painful urination 1.17 (0.88–1.55) 0.518 1.19 (0.85–1.65) 0.467 1.19 (0.87–1.63) 0.698
Menstrual issues 1.07 (0.81–1.41) 0.769 1.27 (0.92–1.75) 0.285 1.20 (0.88–1.63) 0.695
Vaginal discharge 0.85 (0.63–1.13) 0.483 1.45 (1.02–2.08) 0.113e 1.26 (0.90–1.75) 0.573
Urethral discharge 0.88 (0.67–1.17) 0.608 1.55 (1.10–2.17) 0.020 1.09 (0.79–1.49) 0.954
Body rash 0.98 (0.74–1.30) 0.932 1.22 (0.88–1.68) 0.396 1.01 (0.74–1.38) 0.986
Fever 0.92 (0.70–1.22) 0.745 1.69 (1.23–2.34) 0.011 1.00 (0.73–1.36) 0.996
Frequent diarrhea 1.17 (0.85–1.59) 0.567 1.23 (0.86–1.75) 0.419 0.88 (0.62–1.24) 0.908
Frequent coughing 1.33 (0.95–1.87) 0.267 1.41 (0.96–2.06) 0.182 1.05 (0.72–1.53) 0.971
Frequent Sore throat 1.13 (0.79–1.60) 0.745 1.22 (0.82–1.82) 0.459 1.08 (0.73–1.58) 0.971
Weight loss 0.94 (0.71–1.26) 0.794 1.21 (0.87–1.68) 0.418 0.84 (0.61–1.15) 0.698
No symptoms 1.14 (0.79–1.64) 0.664 1.45 (0.93–2.27) 0.217 1.11 (0.74–1.65) 0.961
Transmission
Sexual intercourse 0.57 (0.19–1.72) 0.549 0.69 (0.21–0.28) 0.724 0.85 (0.26–2.79) 0.971
Skin contact 0.89 (0.67–1.19) 0.640 1.71 (1.24–2.37) 0.011 1.27 (0.93–1.73) 0.500
Sharing objects 0.45 (0.34–0.61) 1.8 * 10 −6 1.43 (1.00–2.05) 0.131 0.97 (0.70–1.35) 0.971
Sharing foodc 0.66 (0.50–0.88) 0.020 0.52 (0.37–0.72) 0.004 0.92 (0.67–1.24) 0.947
Swimming poolsc 2.42 (1.73–3.40) 1.8 * 10 −6 0.65 (0.43–0.99) 0.117e 0.90 (0.62–1.31) 0.947
Blood and injections 1.54 (0.96–2.47) 0.216 1.75 (0.97–3.18) 0.153 1.10 (0.66–1.81) 0.971
Hairdressing 0.82 (0.59–1.13) 0.430 1.98 (1.30–3.02) 0.011 1.24 (0.86–1.79) 0.675
Pregnancy and childbirth 1.30 (0.98–1.72) 0.209 1.61 (1.16–2.24) 0.026 1.43 (1.05–1.95) 0.180e
Breastfeeding 1.90 (1.43–2.53) 7.9 * 10 −5 1.59 (1.15–2.20) 0.030 1.37 (1.01–1.87) 0.259e
Mosquito bitec 0.85 (0.64–1.13) 0.483 0.65 (0.46–0.91) 0.052e 0.77 (0.56–1.06) 0.462
Risk factors
Multiple partners 1.28 (0.56–3.05) 0.745 1.12 (0.41–3.06) 0.892 1.07 (0.42–2.76) 0.971
Unprotected sex 2.55 (1.67–3.90) 9 * 10 −5 1.40 (0.88–2.21) 0.285 1.07 (0.71–1.63) 0.971
Substance use 0.76 (0.56–1.03) 0.216 1.30 (0.90–1.86) 0.290 0.73 (0.53–1.01) 0.300
Prostitution 1.28 (0.74–2.21) 0.608 1.42 (0.72–2.78) 0.467 1.40 (0.74–2.64) 0.720
STI co-infection 1.16 (0.68–1.98) 0.745 2.20 (1.03–4.71) 0.113e 1.20 (0.66–2.20) 0.947
Multiple marriages 0.28 (0.21–0.39) 3.6 * 10 −14 1.47 (1.02–2.13) 0.113e 0.91 (0.66–1.27) 0.947
Prevention
Abstinenced 0.99 (0.75–1.31) 0.976 1.11 (0.80–1.53) 0.724 0.73 (0.54–1.00) 0.259e
Condoms 2.06 (1.42–3.00) 0.001 1.51 (0.98–2.32) 0.153 1.59 (1.05–2.40) 0.187e
Single partner 0.33 (0.21–0.51) 3 * 10 −6 0.82 (0.51–1.31) 0.591 0.63 (0.41–0.99) 0.259e
Routine check-up 0.36 (0.18–0.70) 0.011 1.21 (0.55–2.69) 0.768 0.66 (0.34–1.30) 0.675
Vaccines (warts) 0.64 (0.42–0.96) 0.115e 0.98 (0.61–1.57) 0.953 1.04 (0.66–1.63) 0.971
Vaccines (HIV)c 1.51 (1.13–2.00) 0.024 0.70 (0.51–0.97) 0.107e 0.93 (0.68–1.26) 0.971
Showering before and after sexc 1.38 (0.83–2.30) 0.425 0.88 (0.47–1.62) 0.783 1.01 (0.58–1.78) 0.995
Contraceptive pill 1.01 (0.76–1.34) 0.976 0.69 (0.50–0.95) 0.098e 1.02 (0.74–1.39) 0.975
Circumcision 0.96 (0.70–1.31) 0.854 0.98 (0.68–1.39) 0.933 1.03 (0.73–1.45) 0.971
Outcome
Resolution (HIV)c 0.91 (0.66–1.26) 0.745 0.67 (0.47–0.96) 0.107e 0.60 (0.43– 0.85) 0.051e
Resolution (others)c 0.76 (0.57–1.02) 0.209 0.78 (0.56–1.09) 0.270 0.95 (0.69–1.30) 0.971
Infertility 1.01 (0.76–1.34) 0.976 1.08 (0.78–1.49) 0.772 1.11 (0.82–1.51) 0.947
Abortion 0.75 (0.56–1.00) 0.173e 1.30 (0.92–1.83) 0.268 0.98 (0.71–1.34) 0.971
Premature birth 0.76 (0.57–1.00) 0.187 1.10 (0.80–1.52) 0.736 1.46 (1.07–1.98) 0.170e
Birth defects 0.95 (0.72–1.27) 0.798 1.11 (0.80–1.54) 0.724 1.13 (0.82–1.55) 0.908
Kidney problems 1.30 (0.94–1.81) 0.293 1.89 (1.24–2.87) 0.023 1.24 (0.86–1.79) 0.675
Cancer 0.79 (0.59–1.00) 0.275 1.23 (0.88–1.72) 0.396 1.03 (0.75–1.41) 0.971
Death 1.05 (0.79–1.41) 0.798 1.35 (0.95–1.91) 0.212 0.89 (0.65–1.22) 0.908
Information source
School 1.02 (0.77–1.35) 0.932 0.89 (0.65–1.23) 0.669 0.91 (0.67–1.23) 0.947
Healthcare providers 1.23 (0.93–1.63) 0.351 1.63 (1.18–2.26) 0.023 1.29 (0.94–1.75) 0.462
Parents 0.81 (0.60–1.10) 0.383 1.59 (1.14–2.23) 0.035 0.99 (0.71–1.39) 0.995
Friends 2.45 (1.84–3.27) 2.1 * 10 −8 1.71 (1.23–2.38) 0.011 2.04 (1.49–2.80) 3.6 * 10 −4
Books 1.26 (0.95–1.67) 0.293 1.28 (0.92–1.79) 0.270 1.71 (1.24–2.36) 0.018
TV 1.07 (0.81–1.41) 0.769 1.07 (0.77–1.48) 0.787 1.23 (0.90–1.67) 0.608
The Internet 1.54 (0.87–2.74) 0.333 1.21 (0.63–2.33) 0.736 1.20 (0.64–2.23) 0.947

Odds ratios and adjusted p-values for the knowledge about sexually transmitted infections among non-medical undergraduates in Baghdad, Iraq.

aChi-square test was utilized to test for association with a 0.05 cut-off point for statistical significance.

bBenjamin-Hochberg procedure was utilized to adjust for multiple tested and reduce the false discovery rate to 5% within each family of hypothesis testing (within each individual independent variable).

c For these questions, “No” was the correct answer.

d During data collection, abstinence was described as restraining from sexual experience before marriage.

e These items showed statistically significant associations before adjusting for multiple testing.

Supplementary Table 3

Categories Gender Do you know someone who has been diagnosed with an STI?
Odds ratio (95% CI) Adjusted p-valuea, b Odds ratio (95% CI) Adjusted p-valuea, b
Sexually transmitted infections
Can be effectively prevented 0.85 (0.43–1.70) 0.769 1.01 (0.45–2.27) 0.982
Public health campaigns
Have made you reconsider sex 0.86 (0.60–1.24) 0.620 1.27 (0.82–1.98) 0.459
More campaigns are needed 0.88 (0.42–1.84) 0.798 1.25 (0.50–3.11) 0.768
Sex education
Should be taught in middle/high school 0.85 (0.58–1.26) 0.620 1.44 (0.88–2.35) 0.459
Should be a part of science class 0.62 (0.42–0.90) 0.058c 0.93 (0.60–1.45) 0.768
Condoms
Can cause infertility 0.70 (0.50–0.99) 0.161c 1.19 (0.82–1.74) 0.531
Can increase participation in casual sex 0.63 (0.47–0.83) 0.006 0.78 (0.56–1.08) 0.268
Can decrease sexual pleasure 3.14 (2.22–4.45) 1.4 * 10 −9 1.37 (0.95–1.99) 0.212
Can lead to partner mistrust 1.58 (1.19–2.11) 0.011 1.07 (0.77–1.48) 0.787
Are not effective when used as the only infection prevention method 0.52 (0.39–0.70) 9 * 10 −5 0.92 (0.66–1.29) 0.768
Individuals with STIs
Should be socially isolated 1.23 (0.92–1.64) 0.358 1.05 (0.76–1.46) 0.844
Should suffer from violence 1.56 (1.17–2.07) 0.383 1.14 (0.83–1.58) 0.933
Should have fewer jobs 1.22 (0.91–1.65) 0.011 0.97 (0.69–1.38) 0.596
Should be stigmatized by doctors 1.29 (0.97–1.70) 0.221 1.05 (0.76–1.45) 0.844
Categories Previous sexual experience
Odds ratio (95% CI) Adjusted p-value a, b
Sexually transmitted infections
Can be effectively prevented 1.48 (0.64–3.45) 0.788
Public health campaigns
Have made you reconsider sex 0.97 (0.65–1.45) 0.971
More campaigns are needed 1.04 (0.46–2.38) 0.975
Sex education
Should be taught in middle/high school 1.14 (0.73–1.79) 0.947
Should be a part of science class 0.97 (0.63–1.48) 0.971
Condoms
Can cause infertility 0.83 (0.57–1.21) 0.747
Can increase participation in casual sex 0.54 (0.40–0.74) 0.002
Can decrease sexual pleasure 1.50 (1.05–2.15) 0.180c
Can lead to partner mistrust 0.74 (0.54–1.00) 0.270
Are not effective when used as the only infection prevention method 0.79 (0.57–1.08) 0.500
Individuals with STIs
Should be socially isolated 1.00 (0.73–1.37) 0.996
Should suffer from violence 0.89 (0.65–1.21) 0.975
Should have fewer jobs 0.98 (0.71–1.36) 0.908
Should be stigmatized by doctors 0.93 (0.69–1.27) 0.971

Odds ratios and adjusted p-values for attitudes toward sexually transmitted infections, their prevention, and infected individuals among non-medical undergraduates in Baghdad, Iraq.

aChi-square test was utilized to test for association with a 0.05 cut-off point for statistical significance.

bBenjamin-Hochberg procedure was utilized to adjust for multiple tested and reduce the false discovery rate to 5% within each family of hypothesis testing (within each individual independent variable).

cThese items showed statistically significant associations before adjusting for multiple testing.

Supplementary Table 4

Categories Gender Do you know someone who has been diagnosed with an STI?
Odds ratio (95% CI) Adjusted p-valuea, b Odds ratio (95% CI) Adjusted p-valuea, b
Suspicion of having an STI due to symptoms or after high-risk behavior
Ask your parent 0.94 (0.71–1.25) 0.775 0.99 (0.71–1.37) 0.957
Ask a friend 1.72 (1.29–2.29) 0.001 1.10 (0.79–1.53) 0.736
Seek medical advice 1.98 (1.08–3.63) 0.107d 0.95 (0.51–1.78) 0.933
Search the internet 0.79 (0.50–1.24) 0.533 1.01 (0.59–1.74) 0.969
Ignore this suspicion if no symptoms 1.20 (0.89–1.62) 0.450 0.95 (0.67–1.35) 0.844
Diagnosis with an STI
Follow the doctor's advice 0.84 (0.39–1.82) 0.769 0.73 (0.31–1.69) 0.648
Self-medicate with OTC drugsc 0.87 (0.60–1.26) 0.664 1.57 (1.05–2.32) 0.102d
Seek herbal and traditional medicine 1.25 (0.92–1.69) 0.358 1.24 (0.87–1.75) 0.396
Ignore the diagnosis if mild 0.84 (0.57–1.24) 0.608 1.41 (0.93–2.14) 0.227
Categories Previous sexual experience
Odds ratio (95% CI) Adjusted p-value a, b
Suspicion of having an STI due to symptoms or after high-risk behavior
Ask your parent 0.63 (0.45–0.87) 0.056d
Ask a friend 1.25 (0.92–1.71) 0.554
Seek medical advice 1.30 (0.69–2.47) 0.889
Search the internet 0.95 (0.57–1.58) 0.971
Ignore this suspicion if no symptoms 0.91 (0.65–1.27) 0.947
Diagnosis with an STI
Follow the doctor's advice 0.75 (0.33–1.69) 0.933
Self-medicate with OTC drugsc 1.22 (0.83–1.80) 0.747
Seek herbal and traditional medicine 0.96 (0.68–1.35) 0.971
Ignore the diagnosis if mild 0.97 (0.64–1.48) 0.971

Odds ratios and adjusted p-values for practices upon suspicion or diagnosis with a sexually transmitted infection among non-medical undergraduates in Baghdad, Iraq.

aChi-square test was utilized to test for association with a 0.05 cut-off point for statistical significance.

bBenjamin-Hochberg procedure was utilized to adjust for multiple tested and reduce the false discovery rate to 5% within each family of hypothesis testing (within each individual independent variable).

cOTC, over the counter.

d These items showed statistically significant associations before adjusting for multiple testing.

These supplementary analyses may not change the scientific conclusions of the study. However, they identify areas where more caution should be employed when discussing certain significant associations. Namely, the higher knowledge of the genital warts' vaccine and the lower institutional stigma among female students, as well as the higher tendency for self-medication with over-the-counter drugs among those who knew someone with a sexually transmitted infection. Future studies should place higher emphasis on investigating these associations in depth, as they cannot be established with certainty based on these adjustments.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.

    Aoki S . Effect sizes of the differences between means without assuming variance equality and between a mean and a constant. Heliyon. (2020) 6:e03306. 10.1016/j.heliyon.2020.e03306

  • 2.

    Benjamini Y Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. (1995) 57:289300. 10.1111/j.2517-6161.1995.tb02031.x

Summary

Keywords

sexually transmitted infections, sex education, Middle East, Iraq, Baghdad

Citation

Al-Gburi G, Al-Shakarchi A, Al-Dabagh JD and Lami F (2025) Corrigendum: Assessing knowledge, attitudes, and practices toward sexually transmitted infections among Baghdad undergraduate students for research-guided sexual health education. Front. Public Health 13:1617766. doi: 10.3389/fpubh.2025.1617766

Received

24 April 2025

Accepted

23 May 2025

Published

24 June 2025

Volume

13 - 2025

Edited and reviewed by

Christiane Stock, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany

Updates

Copyright

*Correspondence: Ghaith Al-Gburi

†These authors share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics